blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0420459

EP0420459 - Oral pharmaceutical composition for acid sensitive proteinaceous agents [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.08.1992
Database last updated on 30.09.2024
Most recent event   Tooltip20.08.1992Application deemed to be withdrawnpublished on 07.10.1992 [1992/41]
Applicant(s)For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road Morris Plains
New Jersey 07950 / US
[N/P]
Former [1991/14]For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road
Morris Plains New Jersey 07950 / US
Inventor(s)01 / Huang, Hua-Pin
24 Horizon Drive
Succasunna, New Jersey 07876 / US
02 / Ghebre-Sellassie, Isaac
359 Dell Place
Stanhope, New Jersey 07874 / US
03 / Fawzi, Mahdi B.
11 Timberline Drive
Flanders, New Jersey 07836 / US
[1991/14]
Representative(s)Jones, Michael Raymond, et al
Haseltine Lake & Co., Imperial House, 15-19 Kingsway
London WC2B 6UD / GB
[N/P]
Former [1991/14]Jones, Michael Raymond, et al
HASELTINE LAKE & CO. Hazlitt House 28 Southampton Buildings Chancery Lane
London WC2A 1AT / GB
Application number, filing date90310065.914.09.1990
[1991/14]
Priority number, dateUS1989041319727.09.1989         Original published format: US 413197
[1991/14]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0420459
Date:03.04.1991
Language:EN
[1991/14]
Type: A3 Search report 
No.:EP0420459
Date:07.08.1991
Language:EN
[1991/32]
Search report(s)(Supplementary) European search report - dispatched on:EP18.06.1991
ClassificationIPC:A61K9/48, A61K9/32, A61K39/145
[1991/32]
CPC:
A61K9/4891 (EP,US); A61K9/4858 (EP,US); A61K9/4866 (EP,US)
Former IPC [1991/14]A61K9/48, A61K9/32
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/14]
TitleGerman:Orale Arzneimittel mit säurelabilen Proteinwirkstoffen[1991/14]
English:Oral pharmaceutical composition for acid sensitive proteinaceous agents[1991/14]
French:Composition pharmaceutique orale pour des substances protéiniques sensibles aux acides[1991/14]
File destroyed:17.02.2000
Examination procedure08.02.1992Application deemed to be withdrawn, date of legal effect  [1992/41]
13.05.1992Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [1992/41]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]GB1330034  (MO NII VIRUSNYKH PREPARATOV);
 [Y]EP0156242  (CHEMO SERO THERAPEUT RES INST [JP]);
 [Y]EP0192321  (BEECHAM GROUP PLC [GB])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.